Filoviruses: Marburg and ebola

Viral Infections of Humans: Epidemiology and Control

Volumn , Issue , 2014, Pages 337-350

  Ksiazek, Thomas G ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929900719     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4899-7448-8_14     Document Type: Chapter

References (101)

1. Anonymous. Disease transmitted from monkeys to man. Lancet. 1967;2:1129-30.
2. Anonymous. Disease from monkeys. Br Med J. 1967;4:758-9.
3. Anonymous. Outbreak in laboratory personnel working with Cercopithecus monkeys from East Africa-Europe. Wkly Epidemiol Rec. 1968;43:61-2.
4. Gear JS, Cassel GA, Gear AJ, Trappler B, Clausen L, Meyers AM, Kew MC, Bothwell TH, Sher R, Miller GB, et al. Outbreak of Marburg virus disease in Johannesburg. Br Med J. 1975;4(5995): 489-93.
5. Conrad JL, Isaacson M, Smith EB, Wulff H, Crees M, Geldenhuys P, Johnston J. Epidemiologic investigation of Marburg virus disease, Southern Africa, 1975. Am J Trop Med Hyg. 1978;27(6):1210-5.
6. Anonymous. Viral hemorrhagic fever: Sudan and Zaire. Morb Mortal Wkly Rep. 1977;26(26):209-10.
7. Anonymous. Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ. 1978;56(2):247-70.
8. Anonymous. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ. 1978;56(2):271-93.
9. Simpson DI, Zuckerman AJ. Marburg and Ebola: viruses in search of a relation. Nature. 1977;266(5599):217-8.
10. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, Cairns T, Berquist H. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis. 1980;142(3):372-6.
11. Anonymous. Ebola hemorrhagic fever-Southern Sudan. Morb Mortal Wkly Rep. 1979;28(47):557-9.
12. Anonymous. Viral haemorrhagic fever-Sudan. Wkly Epidemiol Rec. 1979;54:319.
13. Richman DD, Cleveland PH, McCormick JB, Johnson KM. Antigenic analysis of strains of Ebola virus: identification of two Ebola virus serotypes. J Infect Dis. 1983;147(2):268-71.
14. Cox NJ, McCormick JB, Johnson KM, Kiley MP. Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. J Infect Dis. 1983;147(2):272-5.
15. Jahrling PB, Geisbert TW, Dalgard DW, Johnson ED, Ksiazek TG, Hall WC, Peters CJ. Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet. 1990;335(8688):502-5.
16. Miranda ME, White ME, Dayrit MM, Hayes CG, Ksiazek TG, Burans JP. Seroepidemiological study of filovirus related to Ebola in the Philippines. Lancet. 1991;337:425-6.
17. Hayes CG, Burans JP, Ksiazek TG, Del Rosario RA, Miranda ME, Manaloto CR, Barrientos AB, Robles CG, Dayrit MM, Peters CJ. Outbreak of fatal illness among captive macaques in the Philippines caused by an Ebola-related filovirus. Am J Trop Med Hyg. 1992;46(6):664-71.
18. Anonymous. Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec. 1992;67(19):142-3.
19. Perini L. Outbreak of Ebola virus in Italy. Folia Primatol. 2000;71(4):280.
20. Rollin PE, Williams J, Bressler D, Pearson S, Cottingham M, Pucak G, Sanchez A, Trappier S, Peters RL, Greer PW, et al. Isolated cases of Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis. 1999;179 suppl 1:S108-14.
21. Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 1995;345:1271-4.
22. Siegert R. Marburg virus, vol. 11. New York: Springer; 1972.
23. Feldmann H, Slenczka W, Klenk HD. Emerging and reemerging of filoviruses. Arch Virol. 1996;11(suppl):77-100.
24. Anonymous. Marburg virus disease-South Africa. Wkly Epidemiol Rec. 1975;50(12):124-25.
25. Smith DH, Johnson BK, Isaacson M, Swanepoel R, Johnson KM, Kiley M, Bagshawe A, Siongok T, Keruga WK. Marburg-virus disease in Kenya. Lancet. 1982;1(8276):816-20.
26. Johnson ED, Johnson BK, Silverstein D, Tukei P, Geisbert TW, Sanchez AN, Jahrling PB. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch Virol. 1996;11(suppl):101-14.
27. Bausch DG, Nichol ST, Muyembe-Tamfum JJ, Borchert M, Rollin PE, Sleurs H, Campbell P, Tshioko FK, Roth C, Colebunders R, et al. Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med. 2006;355:909-19.
28. Anonymous. Outbreak of Marburg haemorrhagic fever: Uganda, June-August 2007. Wkly Epidemiol Rec. 2007;82(43):381-84.
29. Towner JS, Khristova ML, Sealy TK, Vincent MJ, Erickson BR, Bawiec DA, Hartman AL, Comer JA, Zaki SR, Stroher U, et al. Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol. 2006;80(13):6497-516.
30. Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS, Kansiime E, Kagirita A, Ahimbisibwe S, Katunguka F, et al. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda districts, Uganda, 2007. J Infect Dis. 2011;204 suppl 3:S796-9.
31. Anonymous. Imported case of Marburg hemorrhagic fever-Colorado, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(49): 1377-81.
32. Timen A, Koopmans MPG, Vossen ACTM, van Doornum GJJ, Gunther S, van den Berkmortel F, Verduin KM, Dittrich S, Emmerich P, Osterhaus ADME, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis. 2009;15(8):1171-5.
33. Case of Marburg haemorrhagic fever imported into the Netherlands from Uganda. http://www.who.int/csr/don/2008-07-10/en/index.html
34. Green A. Uganda battles Marburg fever outbreak. Lancet. 2012;380(9855):1726.
35. Emond RT, Evans B, Bowen ET, Lloyd G. A case of Ebola virus infection. Br Med J. 1977;2(6086):541-4.
36. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ. 1983;61(6):997-1003.
37. Anonymous. Update: filovirus infection in animal handlers. MMWR Morb Mortal Wkly Rep. 1990;39(13):221.
38. Georges AJ, Leroy EB, Renaut AA, Tevi-Benissan C, Nabias RJ, Ngoc MT, Obiang PI, Mba-Bekale S, Bertherat EJ, Benoni DD, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis. 1999;179 suppl 1:S65-75.
39. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiens B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis. 1999;179 suppl 1:S76-86.
40. Anonymous. Ebola haemorrhagic fever-South Africa. Wkly Epidemiol Rec. 1996;71(47):359.
41. Miranda ME, Ksiazek TG, Retuya TJ, Khan AS, Sanchez A, Fulhorst CF, Rollin PE, Calaor AB, Manalo DL, Roces MC, et al. Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis. 1999;179 suppl 1:S115-9.
42. Okware SI, Omaswa FG, Zaramba S, Opio A, Lutwama JJ, Kamugisha J, Rwaguma EB, Kagwa P, Lamunu M. An outbreak of Ebola in Uganda. Trop Med Int Health. 2002;7(12):1068-75.
43. Anonymous. Outbreak(s) of Ebola haemorrhagic fever, Congo and Gabon, October 2001-July 2002. Wkly Epidemiol Rec. 2003;78(26):223-28.
44. Formenty P, Libama F, Epelboin A, Allarangar Y, Leroy E, Moudzeo H, Tarangonia P, Molamou A, Lenzi M, Ait-Ikhlef K, et al. Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy? Med Trop (Mars). 2003;63(3):291-5.
45. Ebola haemorrhagic fever in the Republic of the Congo-Update 6. http://www.who.int/csr/don/2004-01-06/en/print.html
46. Anonymous. Outbreak of Ebola hemorrhagic fever in Yambio, south Sudan, April-June 2004. Wkly Epidemiol Rec. 2005;80(43): 370-75.
47. Anonymous. Marburg haemorrhagic fever, Democratic Republic of the Congo (Should be Ebola). Wkly Epidemiol Rec. 2007; 82(38):329.
48. MacNeil A, Farnon EC, Wamala JF, Okware S, Cannon DL, Reed ZD, Lutwama J, Downing R, Nichol ST, Ksiazek TG, et al. Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis. 2010;16(12):1969-72.
49. Macneil A, Farnon EC, Morgan OW, Gould P, Boehmer TK, Blaney DD, Wiersma P, Tappero JW, Nichol ST, Ksiazek TG, et al. Filovirus outbreak detection and surveillance: lessons from Bundibugyo. J Infect Dis. 2011;204 suppl 3:S761-7.
50. Outbreak news. Ebola Reston in pigs and humans, Philippines. Wkly Epidemiol Rec. 2009;84(7):49-50.
51. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, Rollin PE, Towner JS, Shieh WJ, Batten B, et al. Discovery of swine as a host for the Reston ebolavirus. Science. 2009;325(5937):204-6.
52. End of Ebola outbreak in the Democratic Republic of the Congo. http://www.who.int/csr/don/2009-02-17/en
53. Shoemaker T, Macneil A, Balinandi S, Campbell S, Wamala JF, McMullan LK, Downing R, Lutwama J, Mbidde E, Stroher U, et al. Reemerging Sudan ebola virus disease in Uganda, 2011. Emerg Infect Dis. 2012;18(9):1480-3.
54. Anonymous. Outbreak news. Ebola haemorrhagic fever, Uganda. Wkly Epidemiol Rec. 2012;87(36):339.
55. Anonymous. Outbreak news. Ebola haemorrhagic fever, Democratic Republic of the Congo. Wkly Epidemiol Rec. 2012;87(36):338-9.
56. Anonymous. Outbreak news. Ebola, Democratic Republic of Congo-update. Wkly Epidemiol Rec. 2012;87(38):357.
57. Anonymous. Outbreak news. Ebola, Democratic Republic of the Congo. Wkly Epidemiol Rec. 2012;87(44):421.
58. Anonymous. Ebola haemorrhagic fever, Uganda-update. Wkly Epidemiol Rec. 2012;87(36):493-508.
59. Anonymous. (2014, 20140426). Ebola virus disease, West Africa-update-20140428. WHO-GAR: disease outbreak news. Retrieved 0430, 2014. http://www.who.int/csr/don/2014-04-28- ebola/en
60. Anonymous. (2014, 20140425). Ebola virus disease, West Africa-update-20140425. WHO-GAR: disease outbreak news. Retrieved 0430, 2014. http://www.who.int/csr/don/2014-04-25- ebola/en
61. Towner JS, Sealy TK, Khristova ML, Albarino CG, Conlan S, Reeder SA, Quan PL, Lipkin WI, Downing R, Tappero JW, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4(11):e1000212.
62. Wamala JF, Lukwago L, Malimbo M, Nguku P, Yoti Z, Musenero M, Amone J, Mbabazi W, Nanyunja M, Zaramba S, et al. Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008. Emerg Infect Dis. 2010;16(7):1087-92.
63. Negredo A, Palacios G, Vázquez-Morón S, González F, Dopazo H, Molero F, Juste J, Quetglas J, Savji N, de la Cruz MM, et al. Discovery of an ebolavirus-like filovirus in Europe. PLoS Pathog. 2011;7(10):e1002304.
64. Feldmann H, Mühlberger E, Randolf A, Will C, Kiley MP, Sanchez A, Klenk HD. Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res. 1992;24(1):1-19.
65. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Muhlberger E, Bray M, Klenk H-D, Palese P, Garcia-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol. 2003;77(14):7945-56.
66. Valmas C, Basler CF. Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J Virol. 2011;85(9):4309-17.
67. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J Virol. 2010;84(2):1169-75.
68. Bwaka MA, Bonnet M-J, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo (former Zaire): clinical observations. J Infect Dis. 1999;179 suppl 1:S1-7.
69. Peters CJ, Zaki SR, and Rollin P. Viral hemorrhagic fevers. In: Mandell GL, and Fekety R, (ed.). Atlas of Infectious Diseases. Volume VIII. External manifestations of systemic infections. Philadelphia: Chruchill Livingstone; 1997. p. 10.2-10.26.
70. Zaki SR, Kilmarx PH. Ebola virus hemorrhagic fever, vol. Chap 17. Washington: ASM Press; 1997.
71. Zaki SR, Peters CJ. Viral hemorrhagic fevers. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, and Lack EE, (ed.). The Pathology of Infectious Diseases, vol. 2. Norwalk: Appleton &Lange; 1997. p. 347-364.
72. Zaki SR, Shieh W-J, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tchioko K, Bwaka MA, Swanepoel R, Calain P, et al. A novel immunohistochemical assay for detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. J Infect Dis. 1999;179 suppl 1:S36-47.
73. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis. 1999;179 suppl 1:S192-8.
74. Ksiazek TG, Rollin PE, Williams AJ, Bresler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, et al. Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179 suppl 1:S177-87.
75. Sanchez A, Feldmann H. Detection of Marburg and Ebola virus infections by polymerase chain reaction assays. Berlin/Heidelberg: Springer; 1995.
76. Towner JS, Rollin PE, Bausch DG, Sanchez A, Crary SM, Vincent M, Lee WF, Spiropoulou CF, Ksiazek TG, Lukwiya M, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol. 2004;78(8):4330-41.
77. Khan AS, Kweteminga TF, Heymann DH, Le Guenno B, Nabeth P, Kerstiens B, Freerackers Y, Kilmarx PH, Rodier GR, Nkuku O, et al. The reemergence of Ebola hemorrhagic fever (EHF), Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179 suppl 1:S76-86.
78. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ, Kikwit ftCdLclEà. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999; 179 (suppl 1):S87-91.
79. Roels TH, Bloom AS, Buffington J, Muhungu GL, MacKenzie WR, Khan AS, Ndambi R, Noah DL, Rolka HR, Peters CJ, et al. Ebola hemorrhagic fever, Kikwit, Democratic Republic of Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis. 1999;179 suppl 1:S92-7.
80. Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012;8(10):e1002877.
81. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, Swanepoel R, Paddock CD, Balinandi S, Khristova ML, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009;5(7):e1000536.
82. Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, Grard G, Ksiazek TG, Gonzalez JP, Nichol ST, Leroy EM. Marburg virus infection detected in a common African bat. PLoS ONE. 2007;2(1):e764.
83. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 2009;9(6):723-8.
84. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Delicat A, Paweska JT, Gonzalez J-P, Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature. 2005;438:575-6.
85. Smith DH, Francis DP, Simpson DIH, Highton RB. The Nzara outbreak of viral haemorrhagic fever. Amsterdam: Elsevier/North-Holland Biomedical Press; 1978.
86. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, Kemp A, Burt FJ, Grobbelaar AA, Croft J, Bausch DG, et al. Studies of reservoir hosts for Marburg virus. Emerg Infect Dis. 2007;13(12):1847-51.
87. Sullivan NJ, Sanchez A, Rollin PE, Yang Z-Y, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature. 2000;408(6812):605-9.
88. Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk H-D, Sullivan NJ, Volchkov VE, Fritz EA, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med. 2004;11(7):786-90.
89. Jones SM, Feldmann H, Stroher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med. 2005;11(7):786-90.
90. Geisbert TW, Daddario-Dicaprio KM, Geisbert JB, Reed DS, Feldmann F, Grolla A, Stroher U, Fritz EA, Hensley LE, Jones SM, et al. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine. 2008;26(52):6894-900.
91. Geisbert TW, Geisbert JB, Leung A, Daddario-DiCaprio KM, Hensley LE, Grolla A, Feldmann H. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus. J Virol. 2009;83(14):7296-304.
92. Feldmann H, Jones SM, Daddario-DiCaprio KM, Geisbert JB, Stroher U, Grolla A, Bray M, Fritz EA, Fernando L, Feldmann F, et al. Effective post-exposure treatment of Ebola infection. PLoS Pathog. 2007;3(1):e2.
93. Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, et al. Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med. 2012;4(138):138ra181.
94. Olinger Jr GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, et al. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci U S A. 2012;109(44):18030-5.
95. Marzi A, Yoshida R, Miyamoto H, Ishijima M, Suzuki Y, Higuchi M, Matsuyama Y, Igarashi M, Nakayama E, Kuroda M, et al. Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of ebola hemorrhagic Fever. PLoS One [Electronic Resource]. 2012;7(4):e36192.
96. Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-Dicaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JR, et al. Postexposure protection of guinea pigs against a lethal ebola virus challenge is conferred by RNA interference. J Infect Dis. 2006;193(12):1650-7.
97. Geisbert TW, Lee ACH, Robbins M, Geisbert JB, Honko AN, Sood V, Johnson JC, de Jong S, Tavakoli I, Judge A, et al. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet. 2010;375(9729):1896-905.
98. Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iversen PL, Bavari S. Genespecifi c countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog. 2006;2(1):5-13.
99. Friedrich BM, Trefry JC, Biggins JE, Hensley LE, Honko AN, Smith DR, Olinger GG. Potential vaccines and post-exposure treatments for filovirus infections. Viruses. 2012;4(9):1619-50.
100. Aebersold P. FDA experience with medical countermeasures under the animal rule. Adv Prev Med. 2012;2012:507571.
101. Dolgin E. Animal rule for drug approval creates a jungle of confusion. Nat Med. 2013;19(2):118-9.